These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 689227)

  • 61. Anthralin and chrysarobin: a reexamination of the origins and early use.
    Steger JW; Hollander A
    Arch Dermatol; 1982 Sep; 118(9):625-6. PubMed ID: 7114862
    [No Abstract]   [Full Text] [Related]  

  • 62. Simplified dithranol treatment for psoriasis.
    Seville RH
    Br J Dermatol; 1975 Aug; 93(2):205-8. PubMed ID: 1100095
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Modern psoriasis therapy].
    Mahrle G
    Z Hautkr; 1984 May; 59(10):645-6. PubMed ID: 6741203
    [No Abstract]   [Full Text] [Related]  

  • 64. [PUVA and anthraline therapy of psoriasis, a clinical, histological and autoradiographic comparison].
    Pullmann H; Zingheim M; Steigleder GK; Orfanos CE
    Z Hautkr; 1976 Oct; 51(20):861-71. PubMed ID: 983210
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clobetasol propionate ointment compared with dithranol in Lassar's paste in the treatment of psoriasis.
    Marriott PJ; Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():101-6. PubMed ID: 1268069
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Dithranol irritation in psoriasis treatment: a study of 68 inpatients.
    Kucharekova M; Lieffers L; van de Kerkhof PC; van der Valk PG
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):176-9. PubMed ID: 15752286
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Dynamics of regression of psoriatic changes under the effect of cygnoline in the light of ultrastructural studies. II. Psoriatic changes after treatment with cygnoline].
    Szczeklik-Franek A; Rubisz-Brzezińska JA; Grzybek H
    Patol Pol; 1979; 30(1):43-8. PubMed ID: 503597
    [No Abstract]   [Full Text] [Related]  

  • 68. [Topical treatment of psoriasis].
    Suhonen R
    Duodecim; 1985; 101(11):1135-41. PubMed ID: 4017905
    [No Abstract]   [Full Text] [Related]  

  • 69. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
    Remitz A
    Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Current state and prospects of the use of cygnoline in the treatment of psoriasis].
    Ciesielska J
    Przegl Dermatol; 1985; 72(1):77-90. PubMed ID: 3892593
    [No Abstract]   [Full Text] [Related]  

  • 71. Treatment of psoriasis with the Ingram anthralin paste regimen.
    Ross JB; Guptill J
    Can Med Assoc J; 1982 Mar; 126(5):496. PubMed ID: 7066806
    [No Abstract]   [Full Text] [Related]  

  • 72. [Dithranol and combined treatment procedures: pro and con].
    Mahrle G; Schulze HJ; Steigleder GK
    Hautarzt; 1985 Jan; 36(1):34-9. PubMed ID: 3972577
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Treatment of psoriasis using Cignolin (dihydroxyanthranol): CSP (Cignolin-Salicylic acid-Petrolatum) - treatment schedule from Cologne].
    Orfanos CE; Steigleder GK
    Z Hautkr; 1976 Jun; 51(12):473-80. PubMed ID: 952029
    [No Abstract]   [Full Text] [Related]  

  • 74. Anthralin therapy for psoriasis.
    Statham BN; Ryatt KS; Rowell NR
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 1):303-4. PubMed ID: 6480932
    [No Abstract]   [Full Text] [Related]  

  • 75. [Our experience with Ingram's treatment of psoriasis modified by Farbes and Harris].
    Vilata JJ; de la Cuadra J; Aliaga A; Marquina A
    Actas Dermosifiliogr; 1974; 65(5-6):254-8. PubMed ID: 4467697
    [No Abstract]   [Full Text] [Related]  

  • 76. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC; van der Valk PG; Swinkels OQ; Kucharekova M; de Rie MA; de Vries HJ; Damstra R; Oranje AP; de Waard-van der Spek FB; van Neer P; Lijnen RL; Kunkeler AC; van Hees C; Haertlein NG; Hol CW
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of dithranol and butantrone in short contact therapy of psoriasis.
    Göransson A
    Acta Derm Venereol; 1987; 67(2):149-53. PubMed ID: 2438880
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Advances in the use of anthralin.
    Seville RH
    J Am Acad Dermatol; 1981 Sep; 5(3):319-21. PubMed ID: 7263977
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of psoriasis vulgaris: gentleness to the entire psoriatic skin and the use of low concentrations of anthralin.
    Brody I
    Br J Dermatol; 1981 Aug; 105 Suppl 20():109-10. PubMed ID: 7284255
    [No Abstract]   [Full Text] [Related]  

  • 80. Anthralin inhibition of intraepidermal pustule formation.
    Stone OJ
    Int J Dermatol; 1986 Mar; 25(2):136. PubMed ID: 3699956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.